Evolving treatment strategies for invasive Streptococcus pyogenes in children in the postpandemic era
Our findings highlight how treatment strategies and disease patterns have shifted in the postpandemic period. Pneumonia with a parapneumonic abscess or empyema has emerged as the most frequent clinical presentation, with nearly half of such cases requiring second-line linezolid therapy. Linezolid may be a valuable treatment alternative after beta-lactam and clindamycin failure. IVIG has been used in severe cases but often late, warranting further investigation into its optimal application.
Authors
- Giuseppe Indolfi (ORCID: https://orcid.org/0000-0003-3830-9823)
- Elisabetta Venturini (ORCID: https://orcid.org/0000-0002-0048-3933)
- Luisa Galli (ORCID: https://orcid.org/0000-0002-7912-3366)
- Elena Chiappini (ORCID: https://orcid.org/0000-0002-1476-4752)
- Marco Renni (ORCID: https://orcid.org/0009-0007-7946-5829)
- Laura Buricchi
Institutions
- Meyer Children's Hospital (IT)
- University of Florence (IT)
Publication Details
- Journal
- Clinical and Experimental Pediatrics
- Published
- 2025-08-11
- DOI
- https://doi.org/10.3345/cep.2025.00479
- Citations
- 2
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.76